Quidel Corporation
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $17.0M | 583 | 77.0% |
| Consulting Fee | $3.1M | 262 | 14.2% |
| Current or prospective ownership or investment interest | $751,300 | 10 | 3.4% |
| Royalty or License | $588,376 | 37 | 2.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $254,943 | 33 | 1.2% |
| Food and Beverage | $136,191 | 3,386 | 0.6% |
| Honoraria | $123,944 | 54 | 0.6% |
| Travel and Lodging | $75,930 | 79 | 0.3% |
| Education | $4,100 | 3 | 0.0% |
| Debt forgiveness | $675.67 | 7 | 0.0% |
| Gift | $84.44 | 4 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| SARS | $5.2M | 0 | 82 |
| Sofia 2 RVP4 | $1.3M | 0 | 17 |
| CS-0605-03: Savanna RVP4 Validation Study | $1.3M | 0 | 31 |
| Strep 98 | $959,320 | 1 | 67 |
| CS-0103-04: QuickVue Flu and QuickVue RSV Field Study | $905,055 | 0 | 21 |
| CS-0908-01:High Sensitivity Near Patient Cardiac Troponin (High Note) - Triage | $846,341 | 0 | 35 |
| CS-0172-01: QuickVue ABC Validation Study | $665,177 | 0 | 4 |
| CS-274-07: Sofia RVP4 Validation Study with New Cassette Format | $632,832 | 0 | 11 |
| QuickVue at Home | $549,939 | 0 | 19 |
| Sofia2 Lyme Disease | $431,867 | 0 | 24 |
| RVP4 | $407,965 | 1 | 13 |
| QuickVue Influenza A+B | $397,008 | 0 | 20 |
| CS-0393-03: Lyra Direct SARS-CoV-2 and Lyra SARS-CoV-2 Validation Study | $369,327 | 0 | 10 |
| Feasibility Testing on Self-Collected Samples with Nexus Labs | $340,545 | 0 | 15 |
| CS-0290-01: Sofia SARS+ Validation Study | $306,487 | 0 | 12 |
| Rapid Influenza Nasal Home Collection Kit | $296,039 | 0 | 8 |
| CS-0908-01-High Note | $253,724 | 6 | 70 |
| CS-0393-01: Lyra Direct SARS CoV-2 Specimen Procurement | $222,250 | 0 | 21 |
| Sofia Lyme Disease | $207,483 | 0 | 22 |
| CS-0164-07: QuickVue At-Home COVID-19 Validation | $121,600 | 0 | 2 |
| Sofia 2 Flu + SARS | $112,593 | 0 | 4 |
| CS-289-02: Sofia Flu and Flu + SARS Comparison Study | $94,993 | 0 | 2 |
| Covid-19 Sophia | $84,566 | 0 | 2 |
| Triage Tox Ds X | $79,020 | 0 | 1 |
| Savanna RVP4/11 Validation Study CS-0605-02 | $78,468 | 0 | 3 |
| CS-0605-04 :Savanna RVP4+ Reproducibility Study | $64,000 | 0 | 2 |
| Sofia2 Strep A | $59,250 | 0 | 7 |
| QuickVue At-Home COVID-19 Reproducibility Study | $57,000 | 0 | 1 |
| CS-0921-01:Sample Collection for the Alignment of Triage BNP on the Quidel Triage MeterPro and the Beckman Coulter Immunoassay System (LEGEND-2) | $53,405 | 0 | 7 |
| Flu+SARS Validation Study | $46,910 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors — Page 7
| Doctor | Specialty | Location | Total | 2019 |
|---|---|---|---|---|
| Dr. Leslie Katz, M.d, M.D | Ophthalmology | Philadelphia, PA | $221.33 | $0 |
| Dr. Michael Farbowitz, M.d, M.D | Ophthalmology | Short Hills, NJ | $220.12 | $0 |
| Alan Carlson, M.d, M.D | Hematology | Durham, NC | $213.52 | $0 |
| Nicola Kim, Md, MD | Ophthalmology | Little Rock, AR | $213.52 | $0 |
| Anthony Kuo, Md, MD | Ophthalmology | Durham, NC | $213.52 | $0 |
| Dr. Robin Vann, M.d, M.D | Ophthalmology | Durham, NC | $213.52 | $0 |
| Dr. Melissa Daluvoy, M.d, M.D | Ophthalmology | Durham, NC | $213.52 | $0 |
| Dr. Amanda Johnson, Od, OD | Optometrist | Wake Forest, NC | $213.52 | $0 |
| Thomas Hunter, Md, MD | Ophthalmology | Durham, NC | $213.52 | $0 |
| Steven Silverstein, Md, MD | Ophthalmology | Kansas City, MO | $210.26 | $0 |
| Thomas Nettleton, Od, OD | Optometrist | San Antonio, TX | $210.00 | $0 |
| Dr. Rahul Tonk, Md, Mba, MD, MBA | Ophthalmology | Princeton, NJ | $203.10 | $0 |
| Dr. Anith Pillai, O.d, O.D | Vision Therapy | Sugar Land, TX | $202.84 | $0 |
| Inder Singh | Ophthalmology | Racine, WI | $201.85 | $0 |
| Anna Marie Chang, Md, MD | Emergency Medicine | Philadelphia, PA | $200.00 | $0 |
| John C Fox, Md, MD | Emergency Medicine | Orange, CA | $200.00 | $0 |
| James Williams, D.o, D.O | Emergency Medicine | San Antonio, TX | $200.00 | $0 |
| Dr. Spencer Greene, M.d, M.D | Emergency Medicine | Kingwood, TX | $200.00 | $0 |
| Dr. Nechama Shoshani, M.d, M.D | Ophthalmology | Rockville Centre, NY | $199.90 | $0 |
| Ralph Sando, Md, MD | Ophthalmology | Ardmore, PA | $199.81 | $0 |
| Dr. Charles Sung, Md, MD | Ophthalmology | Kennewick, WA | $198.48 | $0 |
| Unknown Provider | — | — | $192.49 | $0 |
| Justin Roman, M.d, M.D | Cornea and External Diseases Specialist | Greenville, SC | $190.69 | $0 |
| Selina Mcgee, O.d, O.D | Optometrist | Edmond, OK | $185.81 | $0 |
| Alyssa Anderson, O.d, O.D | Optometrist | Rock Island, IL | $181.08 | $0 |
Top Products
- Sofia2 $7.1M
- QuickVue $2.8M
Associated Products (19)
- Sofia2 $7.1M
- QuickVue $3.4M
- Triage $2.7M
- Sofia 2 $982,290
- QuickVue At-Home $619,924
- Eye Health $426,338
- R-Mix $380,546
- Savanna $173,377
- Quickvue At-Home $150,107
- QuickVue Professional Use $106,000
- FGF-23 $78,802
- TBI $56,664
- InflammaDry $52,594
- Sofa 2 $46,569
- Super E-Mix $40,919
- MicroVue Bone $31,977
- Solana $27,320
- TriageTrue $13,725
- MicroVue $12,388
Payment Categories
- Food & Beverage $136,191
- Consulting $3.1M
- Travel & Lodging $75,930
- Research $17.0M
- Royalties $588,376
About Quidel Corporation
Quidel Corporation has made $22.1M in payments to 2,500 healthcare providers, recorded across 4,458 transactions in the CMS Open Payments database. In 2023, the company paid $6.7M. The top product by payment volume is Sofia2 ($7.1M).
Payments were distributed across 100 medical specialties. The top specialty by payment amount is Obstetrics & Gynecology ($2.3M to 29 doctors).
Payment categories include: Food & Beverage ($136,191), Consulting ($3.1M), Research ($17.0M), Travel & Lodging ($75,930), Royalties ($588,376).
Quidel Corporation is associated with 19 products in the CMS Open Payments database, including Sofia2, QuickVue, and Triage.